Lutetium-177 in the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Lutetium-177 in the Treatment of Metastatic Castrate-Resistant Pro…
607 viewsSep 1, 2023
vumedi.com
Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) - UChicago Medicine
Lutetium-177 PSMA Therapy for Prostate Cancer (Pluvicto) - UChic…
Jun 17, 2022
uchicagomedicine.org
Provenge Advanced Prostate Cancer Treatment
Provenge Advanced Prostate Cancer Treatment
Jan 21, 2025
uclahealth.org
Lutetium-177 este un tratament revoluționar pentru cancerul metastatic, care oferă oportunități noi de vindecare! Acest izotop radioactiv targetează direct celulele canceroase, minimizând daunele asupra țesuturilor sănătoase. | Acibadem Servicii Medicale
1:29
Lutetium-177 este un tratament revoluționar pentru cancerul meta…
16.3K viewsJan 31, 2025
FacebookAcibadem Servicii Medicale
Lutetium 177 production | production of Lu177 | Isotopia Ltd
Lutetium 177 production | production of Lu177 | Isotopia Ltd
Feb 10, 2020
isotopia-global.com
Lutetium Lu 177 Dotatate Shows Promise in Advanced Intracranial Meningioma | OncLive
1:12
Lutetium Lu 177 Dotatate Shows Promise in Advanced Intracranial …
3 months ago
onclive.com
Terbium-161 vs Lutetium-177: Comparing Next-Gen Radioligands for Prostate Cancer - Michael Hofman
Terbium-161 vs Lutetium-177: Comparing Next-Gen Radioligand…
9 months ago
urotoday.com
Dr Tagawa on the Evaluation of Lutetium Lu 177 Rospatamab Tetraxetan Plus SOC in mCRPC | OncLive
Dr Tagawa on the Evaluation of Lutetium Lu 177 Rospatamab Tetr…
1 month ago
onclive.com
Dr Morris on the FDA's Expanded Approval of Lutetium Lu 177 Vipivotide Tetraxetan for PSMA mCRPC | OncLive
Dr Morris on the FDA's Expanded Approval of Lutetium Lu 177 Vipiv…
11 months ago
onclive.com
Dr Garrot on Lutetium Lu 177 Vipivotide Tetraxetan in Older Patients with MCRPC | OncLive
Dr Garrot on Lutetium Lu 177 Vipivotide Tetraxetan in Older Pati…
Nov 7, 2024
onclive.com
Dr Srinivas on the Role of Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC | OncLive
2:04
Dr Srinivas on the Role of Lutetium Lu 177 Vipivotide Tetraxetan in m…
Sep 19, 2024
onclive.com
Dr Garcia on the Effect of the Expanded Approval of Lutetium Lu 177 Vipivotide Tetraxetan in in PSMA mCRPC | OncLive
Dr Garcia on the Effect of the Expanded Approval of Lutetium L…
10 months ago
onclive.com
Dr Dorff on the Safety of Lutetium Lu 177 Vipivotide Tetraxetan in mCRPC With Renal Impairment | OncLive
1:30
Dr Dorff on the Safety of Lutetium Lu 177 Vipivotide Tetraxetan in m…
11 months ago
onclive.com
Scanning Methods and Treatment Selection | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Scanning Methods and Treatment Selection | Targeted Oncology - I…
8 months ago
targetedonc.com
Telix Pharmaceuticals Limited Provides Update on global Phase 3 ProstACT study of Prostate Cancer Therapy TLX591
Telix Pharmaceuticals Limited Provides Update on global Phase …
3 months ago
marketscreener.com
PSMA-Targeted Radioligand Therapy in Advanced Prostate Cancer | OncLive
PSMA-Targeted Radioligand Therapy in Advanced Prostate Ca…
Jul 30, 2021
onclive.com
Peter Speek, who is from the USA, had been diagnosed with prostate cancer five years ago. He had received a treatment elsewhere but it re-occured again. In the search of a new and effective treatment, Peter found Memorial Hospital, where lutetium has been practised for the last 10 years and offers easier access to patients compared to USA. Now having received his second and third lutetium treatment at our hospital, we are grateful to be taking part in his journey and for choosing us. | Memorial
1:00
Peter Speek, who is from the USA, had been diagnosed with prostat…
32.9K viewsMar 23, 2023
FacebookMemorial
Dr. Morris on Logistical Challenges of Using 177Lu-PSMA-617 in Prostate Cancer | OncLive
Dr. Morris on Logistical Challenges of Using 177Lu-PSMA-617 in Pros…
Jan 11, 2022
onclive.com
Dr. Gafita on Prognostic Models for Treatment With 177Lu-PSMA-617 in mCRPC | OncLive
Dr. Gafita on Prognostic Models for Treatment With 177Lu-PSMA-617 i…
Aug 5, 2020
onclive.com
Preparing for Treatment with 177Lu-PSMA-617 - Kendra Harris
Preparing for Treatment with 177Lu-PSMA-617 - Kendra Harris
Apr 22, 2022
urotoday.com
177Lu-DOTATATE improves outcomes in advanced GEP-NETs versus octreotide
2:05
177Lu-DOTATATE improves outcomes in advanced GEP-NETs …
2 months ago
YouTubeVJOncology
177Lu-PSMA-617 after sipuleucel-T in mCRPC: PRECISION analysis
1:39
177Lu-PSMA-617 after sipuleucel-T in mCRPC: PRECISION analysis
18 views3 weeks ago
YouTubeVJOncology
LuxAR-02: luxdegalutamide and 177Lu-PSMA-617 in pre-treated mCRPC
0:59
LuxAR-02: luxdegalutamide and 177Lu-PSMA-617 in pre-treated m…
27 views2 weeks ago
YouTubeVJOncology
Lu-177 PSMA Therapy: Clinical Adoption & Future Landscape
39:17
Lu-177 PSMA Therapy: Clinical Adoption & Future Landscape
1 week ago
YouTubeDavid Capobianco
New Cancer Treatment: Radiopharmaceuticals
8:44
New Cancer Treatment: Radiopharmaceuticals
25.8K viewsFeb 22, 2021
YouTubeDemystifying Medicine McMaster
Lutetium (version 1) - Periodic Table of Videos
1:34
Lutetium (version 1) - Periodic Table of Videos
136.6K viewsJul 11, 2008
YouTubePeriodic Videos
Radiation Treatment for Brain Tumor- full procedure
9:15
Radiation Treatment for Brain Tumor- full procedure
6.6M viewsJul 23, 2014
YouTubeBob Dewey
How PRRT Can Improve Care for Neuroendocrine Tumor Patients
3:47
How PRRT Can Improve Care for Neuroendocrine Tumor Patients
29.8K viewsJan 26, 2018
YouTubeNETRF
The Elements Song - Karaoke Backing Track & Animation (Tom Lehrer)
1:22
The Elements Song - Karaoke Backing Track & Animation (Tom …
146.4K viewsOct 7, 2009
YouTubePaul Cohen
Ableton Live Tutorial: Vocal Processing Effects + Live Performance Tips
16:19
Ableton Live Tutorial: Vocal Processing Effects + Live Perform…
906K viewsJan 30, 2012
YouTubeDubspot
See more